Cargando…
The Evolving Concept of Poor-Prognosis for Women Undertaking IVF and the Notion of Growth Hormone as an Adjuvant; A Single-Center Viewpoint
IVF is currently regarded as a successful new technology with the number of IVF children currently well over 8 million worldwide. This has been achieved by an explosive plethora of facilities. However, from its earliest history, IVF has been beset by poor-prognosis on a treatment cycle basis, an asp...
Autores principales: | Yovich, John L., Ye, Yun, Regan, Sheena L. P., Keane, Kevin Noel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882284/ https://www.ncbi.nlm.nih.gov/pubmed/31824425 http://dx.doi.org/10.3389/fendo.2019.00808 |
Ejemplares similares
-
The Concept of Growth Hormone Deficiency Affecting Clinical Prognosis in IVF
por: Yovich, John L., et al.
Publicado: (2019) -
DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis
por: Keane, Kevin N., et al.
Publicado: (2018) -
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis
por: Keane, Kevin N, et al.
Publicado: (2017) -
Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve
por: Hart, Roger J.
Publicado: (2019) -
Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosis
por: Keane, Kevin N, et al.
Publicado: (2019)